Fulfilling the promise: Drug discovery in the post-genomic era

Drug Discovery Today

Volumn 8, Issue 4, 2003, Pages 168-174

  Chanda, Sumit K ^a   Caldwell, Jeremy S ^a  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLOSPORIN A; DYCLONINE; FUMAGILLOL CHLOROACETYLCARBAMATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOSUPPRESSIVE AGENT; KENPAULLONE; METHIONYL AMINOPEPTIDASE; OXIDIZING AGENT; PENICILLIN G; PROTEIN INHIBITOR; PROTEOME; TACROLIMUS;

AUTOMATION; CELL FREE SYSTEM; CHEMICAL GENETICS; DNA MICROARRAY; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENE TECHNOLOGY; GENOME ANALYSIS; HUMAN; HUMAN GENOME; METHODOLOGY; NONHUMAN; PROTEIN FUNCTION; REVIEW;

ANIMALS; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE LIBRARY; GENOME, HUMAN; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS;

EID: 0037441560     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02595-3     Document Type: Review

References (52)

1. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
2. Venter J.C., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
3. Broder S., Venter J.C. Sequencing the entire genomes of free-living organisms: the foundation of pharmacology in the new millennium. Annu. Rev. Pharmacol. Toxicol. 40:2000;97-132.
4. Chee M., et al. Accessing genetic information with high-density DNA arrays. Science. 274:1996;610-614.
5. Schena M., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
6. Schuldiner O., Benvenisty N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene. 20:2001;4984-4994.
7. Ma Y., et al. Identification of novel E2F1-regulated genes by microarray. Arch. Biochem. Biophys. 399:2002;212-224.
8. Shaffer A.L., et al. Signatures of the immune response. Immunity. 15:2001;375-385.
9. Panda S., et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 109:2002;307-320.
10. Alizadeh A.A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
11. Perou C.M., et al. Molecular portraits of human breast tumours. Nature. 406:2000;747-752.
12. Yan D., et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14973-14978.
13. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
14. Simonsen H., Lodish H.F. Cloning by function: expression cloning in mammalian cells. Trends Pharmacol. Sci. 15:1994;437-441.
15. Hitoshi Y., et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 8:1998;461-471.
16. Little P.F., et al. Plasmid vectors for the rapid isolation and transcriptional analysis of human beta-globin gene alleles. Mol. Biol. Med. 1:1983;473-488.
17. Somia N.V., et al. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12667-12672.
18. Foster K.W., et al. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10:1999;423-434.
19. Berquin I.M., et al. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene. 20:2001;4019-4028.
20. Mahlmann S., et al. Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection. Leukemia. 12:1998;1858-1865.
21. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
22. Albala J.S. Array-based proteomics: the latest chip challenge. Expert Rev. Mol. Diagn. 1:2001;145-152.
23. Naaby-Hansen S., et al. Proteomics - post-genomic cartography to understand gene function. Trends Pharmacol. Sci. 22:2001;376-384.
24. Ho Y., et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 415:2002;180-183.
25. Gavin A.C., et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141-147.
26. Ziauddin J., Sabatini D.M. Microarrays of cells expressing defined cDNAs. Nature. 411:2001;107-110.
27. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228:1985;1315-1317.
28. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
29. Rojo-Niersbach E., et al. A new method for the selection of protein interactions in mammalian cells. Biochem. J. 348:2000;585-590.
30. Lo Ten Foe J.R., et al. Expression cloning of a cDNA for the major Fanconi anaemia gene. FAA. Nat. Genet. 14:1996;320-323.
31. Tanaka K., et al. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain. Nature. 348:1990;73-76.
32. Drews J. Drug discovery: a historical perspective. Science. 287:2000;1960-1964.
33. Lenz G.R., et al. Chemical ligands, genomics and drug discovery. Drug Discov. Today. 5:2000;145-156.
34. Schaertl S., et al. A novel and robust homogeneous fluorescence-based assay using nanoparticles for pharmaceutical screening and diagnostics. J. Biomol. Screening. 5:2000;227-238.
35. Moore K.J., et al. Single molecule detection technologies in miniaturized high throughput screening: fluorescence correlation spectroscopy. J. Biomol. Screening. 4:1999;335-354.
36. Kuruvilla F.G., et al. Dissecting glucose signalling with diversity oriented synthesis and small-molecule microarrays. Nature. 416:2002;653-657.
37. Reynolds P.E., et al. Identification of the binding protein which may be the target of penicillin action in Bacillus megaterium. Nature. 271:1978;568-570.
38. Handschumacher R.E., et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226:1984;544-547.
39. Harding M.W., et al. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760.
40. Griffith E.C., et al. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 4:1997;461-471.
41. Taunton J., et al. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 272:1996;408-411.
42. Kragten E., et al. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273:1998;5821-5828.
43. Hughes T.R., et al. Functional discovery via a compendium of expression profiles. Cell. 102:2000;109-126.
44. Zaharevitz D.W., et al. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res. 59:1999;2566-2569.
45. Issaq H.J., et al. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:2002;587-592.
46. Bruenner B.A., et al. Quantitative analysis of oligonucleotides by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 10:1996;1797-1801.
47. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
48. Zhu H., et al. Global analysis of protein activities using proteome chips. Science. 293:2001;2101-2105.
49. Sche P.P., et al. Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem. Biol. 6:1999;707-716.
50. Savinov S.N., Austin D.J. The cloning of human genes using cDNA phage display and small-molecule chemical probes. Comb. Chem. High Throughput Screen. 7:2001;593-597.
51. Yin M.J., et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 396:1998;77-80.
52. Perez O.D., et al. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:2002;51-65.